Pfizer began a profound transformation a decade ago to improve its innovation capabilities and become what it is today: a science-based company dedicated to developing breakthroughs that change patients’ lives. For the other two businesses, Consumer Healthcare and Upjohn, merger or joint venture agreements have been signed with other healthcare players in 2019 and 2020. The new Pfizer, refocused around the Biopharmaceuticals Group entity, ensures our innovation capacity and ability to better address unmet medical needs in a sustainable way. Around the world, our more than 80,000 employees pursue a single goal: to contribute to the discovery, development and distribution of innovative medicines to protect patients and improve their quality of life.
